Use of Stool-derived Eukaryotic RNA (seRNA) to Noninvasively Assess Patients with IBD
Time: 9:30 am
day: Day One
Details:
- Improving detection, selection, and monitoring of treatment response for patients with IBD
- Leveraging technology across a variety of biomarker types, including RNA expression, allele frequencies of expressed RNA variants, and protein concentrations
- User-friendly platform allows periodic monitoring with improved patient engagement and compliance
